Published • loading... • Updated
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Average Target Price of $147.13
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Average Target Price of $147.13
Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) have received an average recommendation of “Moderate Buy” from the eighteen analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year price […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
